Foray Bioscience builds biomanufacturing tools to grow harvest-free plant-based materials, seeds and molecules using plant cell cultures. The company employs a database-driven approach that provides predictive insights and experimental direction to speed R&D across diverse plant species. It partners with other companies to design R&D roadmaps and commercialization strategies for plant biomanufacturing. Founder Ashley Beckwith launched the company in February 2022 to reduce pressure on natural plant resources and support conservation. Foray also aims to create a genetic banking system to document and regrow seeds from only a few cells. The startup has raised $3.875 million to date and plans to build out its team.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Jun 2024